Your browser doesn't support javascript.
loading
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study.
Gu, Yangchun; Yu, Jinyu; Hu, Haifeng; Zhang, Hua; Cao, Baoshan; Liang, Li.
Afiliación
  • Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
  • Yu J; Department of Oncology, Yan'an Hospital of Traditional Chinese Medicine, Shaanxi, China.
  • Hu H; Cancer Center of Peking University Third Hospital, Beijing, China.
  • Zhang H; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
  • Cao B; Cancer Center of Peking University Third Hospital, Beijing, China.
  • Liang L; Department of Oncology, Yan'an Hospital of Traditional Chinese Medicine, Shaanxi, China.
Thorac Cancer ; 14(31): 3147-3160, 2023 11.
Article en En | MEDLINE | ID: mdl-37704565
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Singapur